Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpirax-Sarco Regulatory News (SPX)

Share Price Information for Spirax-Sarco (SPX)

Share Price is delayed by 15 minutes
Get Live Data
6,865.00    170.00 (2.54%)
Bid:
6,860.00
Ask:
6,870.00
Spread: 10.00 (0.146%)
Market Cap: £5.07b
SPX Live PriceLast checked at - London Stock Exchange

Intraday Spirax-Sarco Share Chart

Trading Update

18 Nov 2020 07:00

RNS Number : 6502F
Spirax-Sarco Engineering PLC
18 November 2020
 

 

News Release

 

Wednesday 18th November 2020

TRADING UPDATE

Resilient trading in line with expectations; full year expectations unchanged

 

Thermal energy management and niche pumping specialist, Spirax‐Sarco Engineering plc, issues the following trading update in respect of the four months ended 31st October 2020.

 

Economic environment

As anticipated, the global macro-economic environment improved during the third quarter of the year. Compared with the same period of 2019, global Industrial Production (IP)1 was down 4% in the third quarter, a strong improvement on the 12% contraction in the second quarter. Following robust sequential month-on-month IP growth in June and July, the rate of growth slowed markedly in August and September as industrial activity began to approach pre-pandemic levels.

 

Trading

Despite the challenging economic environment, trading has continued to hold up well. All production facilities remain open and operating without capacity constraints. Our sales engineers remain in close contact with our customers globally, with physical access to customers' facilities improving in those regions that are not subject to new lockdown measures.

 

Consistent with expectations shared at the Half Year results announcement in August, the organic sales decline in the four months to the end of October was less pronounced than in the first half of the year, supported by the recovery of global IP. Overall, the rate at which reported sales declined was marginally less than in the first half of the year, when reported sales benefited from the inclusion of Thermocoax which joined the Group in May 2019.

 

In the Steam Specialties business, organic sales in the four months to October declined less than in the first half of the year as the contraction in IP lessened across all regions and China returned to IP growth.

 

In the Electric Thermal Solutions business, organic sales in the four months to October also declined at a lower rate than in the first half of the year, as a similar organic sales decline in Chromalox was mitigated by strong organic sales growth in Thermocoax.

 

In the Watson-Marlow Fluid Technology Group, organic sales growth was higher in the four months to October compared with the first half of the year, as sales to the Biopharmaceutical sector remained strong and sales to the other industrial sectors recovered in line with global IP. Watson‐Marlow's exposure to the Biopharmaceutical and Medical Device markets makes it more resilient to the impact of COVID‐19, with many customers working on vaccine development and preparing for mass vaccine production.

 

The Group operating profit margin was higher in the four months to the end of October than in the first half of the year, supported by increased sales and continued cost containment actions. In the ten months to the end of October, the Group operating profit margin remained slightly below the same period in the prior year.

 

Currency effects continued to have an adverse impact on sales and operating profit, compared to the same period of 2019, as sterling maintained its strength against our basket of trade currencies. If spot rates at 31st October 2020 prevail for the remainder of the year, the headwind effect on full year sales and profit would be 2% and 4% respectively.

 

Financial position

Our business remains highly cash generative and we maintain a strong balance sheet. Excluding leases, our net borrowings at 31st October 2020 were £254 million, down from £326 million on 30th June 2020. The interim dividend of 33.5p per share was paid on 6th November at a cash cost of £25 million.

 

People

We continue to recognise and appreciate the individual and collective efforts of our 7,800 employees across nearly 70 countries that have allowed us to meet the needs of our customers. We have maintained a strong focus on the health and wellbeing of our employees and, thankfully, the rate of infection amongst our employees remains very low.

As previously announced, Neil Daws, Managing Director Steam Specialties and Executive Director will retire from the Steam Specialties business and the Board on 31st December 2020 after more than 42 years of service. We would again like to thank Neil for his huge contribution to the Group.

We are pleased to announce that Neil's successor, Maurizio Preziosa, will take over as Managing Director Steam Specialties from 1st January 2021 and become a member of the Group Executive Committee. Maurizio will be based at the Group Headquarters in Cheltenham, UK. Maurizio joined the Group in November 2011 as General Manager for Spirax-Sarco Italy, progressing to the role of Regional General Manager for Southern Europe in 2014, before becoming Divisional Director for Gestra in May 2017 where he led the successful integration and growth of the Gestra acquisition.

 

Also as previously announced, Angela Archon and Olivia Qiu will join the Board as Independent Non-Executive Directors effective 1st December 2020.

 

Outlook

After reaching a low point in the second quarter when global IP contracted 12%, macro-economic conditions improved in the third quarter with a global IP contraction of 4%. IP is now forecast to contract by an overall 5.5% in 2020. However, the sequential month-on-month rate of IP growth slowed markedly in August and September, infection rates remain high in the Americas and increasing levels in Europe are resulting in further lockdowns. Although the impact on IP growth in the fourth quarter resulting from the COVID-19 resurgence remains uncertain, these factors could further slow the rate of IP recovery in the final quarter of 2020, as we anticipated at the Half Year results announcement in August.

 

Sales and adjusted operating profit in the four months to the end of October were in line with our expectations at the time of our Half Year results. Therefore, absent a significant global IP deterioration in the remaining months of 2020, our overall expectations for the full year remain unchanged.

 

Spirax-Sarco Engineering plc expects to publish its preliminary 2020 results on 10th March 2021.

 

 

1 Source for industrial production data: Oxford Economics, 6th November 2020.

 

 

Enquiries:

Nicholas Anderson, Group Chief Executive

Nimesh Patel, Chief Financial Officer

Shaun Laubscher, Head of Investor Relations

Tel: 01242 535234

 

Note: Operating profit refers to adjusted operating profit and organic performance measures are expressed at constant currency, excluding contributions from acquisitions and disposals as explained in Note 2 to the Consolidated Financial Statements for the period ended 30th June 2020.

 

About Spirax‐Sarco Engineering plc

Spirax‐Sarco Engineering plc is a thermal energy management and niche pumping specialist. It comprises three world‐leading businesses: Steam Specialties, for the control and management of steam; Electric Thermal Solutions, for advanced electrical process heating and temperature management solutions; and Watson-Marlow, for peristaltic pumping and associated fluid path technologies. The Steam Specialties and Electric Thermal Solutions businesses provide a broad range of fluid control and electrical process heating products, engineered packages, site services and systems expertise for a diverse range of industrial and institutional customers. Both businesses help their end users to improve production efficiency, meet their environmental sustainability targets, improve product quality and enhance the safety of their operations. Watson‐Marlow Fluid Technology Group provides solutions for a wide variety of demanding fluid path applications with highly accurate, controllable and virtually maintenance-free pumps and associated technologies.

 

The Group is headquartered in Cheltenham, UK, has strategically located manufacturing plants around the world and employs over 7,800 people, of whom close to 1,800 are direct sales and service engineers. Its shares have been listed on the London Stock Exchange since 1959 (symbol: SPX) and it is a constituent of the FTSE 100 and the FTSE4Good indices.

 

Further information can be found at www.spiraxsarcoengineering.com

 RNS filter: Inside information prior to release

 

LEI 213800WFVZQMHOZP2W17

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTKKOBQDBDBDDD
Date   Source Headline
6th Jun 20112:49 pmRNSDirector/PDMR Shareholding
6th Jun 20112:46 pmRNSTotal Voting Rights
27th May 20117:00 amRNSDirectorate Change
12th May 20115:23 pmRNSAGM Statement
10th May 20111:00 pmRNSInterim Management Statement
9th May 20111:38 pmRNSHolding(s) in Company
6th May 20114:25 pmRNSTotal Voting Rights
27th Apr 20119:16 amRNSDirector Declaration
6th Apr 20113:34 pmRNSHolding(s) in Company
1st Apr 20114:50 pmRNSDirector/PDMR Shareholding
1st Apr 20114:48 pmRNSTotal Voting Rights
29th Mar 20115:22 pmRNSDirector/PDMR Shareholding
23rd Mar 20114:48 pmRNSAnnual Financial Report
21st Mar 20113:44 pmRNSDirector/PDMR Shareholding
18th Mar 20114:34 pmRNSDirector/PDMR Shareholding
16th Mar 20114:32 pmRNSDirector/PDMR Shareholding
9th Mar 201110:48 amRNSDirector/PDMR Shareholding
8th Mar 20117:00 amRNS2010 Preliminary Results
1st Mar 20119:28 amRNSTotal Voting Rights
3rd Feb 20115:12 pmRNSHolding(s) in Company
1st Feb 201110:52 amRNSTotal Voting Rights
13th Jan 20114:04 pmRNSNotice of Results
5th Jan 201110:06 amRNSTotal Voting Rights
1st Dec 20104:58 pmRNSTotal Voting Rights
15th Nov 20103:24 pmRNSDirector/PDMR Shareholding
8th Nov 20107:00 amRNSInterim Management Statement
1st Nov 20102:08 pmRNSTotal Voting Rights
28th Oct 201010:53 amRNSDirector Declaration
26th Oct 20108:29 amRNSHolding(s) in Company
26th Oct 20108:29 amRNSHolding(s) in Company
19th Oct 20104:20 pmRNSHolding(s) in Company
12th Oct 201011:06 amRNSAmendment - Director/PDMR Shareholding
11th Oct 20104:43 pmRNSDirector/PDMR Shareholding
1st Oct 20101:13 pmRNSTotal Voting Rights
6th Sep 20104:06 pmRNSDirector/PDMR Shareholding
6th Sep 201010:55 amRNSHolding(s) in Company
2nd Sep 201010:39 amRNSTotal Voting Rights
26th Aug 201011:18 amRNSDirector/PDMR Shareholding
24th Aug 20107:00 amRNS2010 Half Year Results
2nd Aug 20104:26 pmRNSTotal Voting Rights
9th Jul 20109:14 amRNSHolding(s) in Company
7th Jul 201011:59 amRNSAcquisition - Replacement Announcement
7th Jul 201011:32 amRNSAcquisition
7th Jul 20109:55 amRNSHolding(s) in Company
6th Jul 20103:35 pmRNSHolding(s) in Company
6th Jul 20108:44 amRNSHolding(s) in Company
6th Jul 20107:00 amRNSTrading update
1st Jul 201011:15 amRNSTotal Voting Rights
17th Jun 201010:01 amRNSDirector Declaration
15th Jun 20102:48 pmRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.